UPDATE: Rathmann Steps Aside as Hyseq CEO after Finding Top Replacement | GenomeWeb

This story has been updated from a previous version.

NEW YORK, March 21 - The decision to promote Ted Love to the position of CEO at Hyseq reflects George Rathmann's confidence in Love's ability to get the company back on track, a spokeswoman said Wednesday.

"George feels Ted is extremely capable," said Dawn Nakao, Hyseq's investor relations manager.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.